TAG Mail 2020 (January - June) Cumulative Listing of Reports, Publications, Medication Safety Information and Papers of Interest TAG Mail – 25 June 2020 COVID-19 RESOURCES & ARTICLES OF INTEREST Please click this link for the cumulative listing of COVID-19 resources in past TAG Mails. AUSTRALIAN ACI Evidence checks: Extended use or reuse of personal protective equipment; Efficacy of cloth face masks for the prevention of COVID-19 transmission – link AHHA - Upcoming event: From the Frontlines: emerging from the COVID-19 pandemic. 26 June 2020 09:00- 10:00 AEST AHPPC - Statement on preliminary media reports of the results of a randomised trial of the use of dexamethasone - link NCCET Living Guidelines updates include: dexamethasone statement, definitions of disease severity, disease modifying treatments – link NPS MedicineWise - Podcast: Episode 5: Quality use of medicines and COVID-19 INTERNATIONAL WHO - Criteria for releasing COVID-19 patients from isolation: scientific brief, 17 June 2020 - link - WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients - link - Hydroxychloroquine arm of Solidarity Trial stops - link - Breastfeeding and COVID-19: scientific brief, 23 June 2020 - link Canada National Collaborating Centre for Methods and Tools - Rapid Review: What is known about the efficacy and cost-effectiveness of copper materials to reduce transmission of viruses? - link UK Care Quality Commission (UK) - COVID-19 Insight: Issue 2 CEBM - Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19 - link Department of Health and Social Care - Joint Committee on Vaccination and Immunisation: interim advice on priority groups for COVID-19 vaccination - link NICE - NG178 COVID 19 rapid guideline: renal transplantation NIHR - First human trials of new COVID-19 vaccine to start - link Royal Coll of GPs - GPs predict ‘huge surge’ in patients with Post Traumatic Stress Disorder due to COVID-19 - link Royal Coll Physicians - Clinical guide for the prevention, detection and management of thromboembolic disease in patients with COVID-19 - link USA AHRQ - Masks for Prevention of COVID-19 in Community and Healthcare Settings: A Living Rapid Review - link American Society of Health-System Pharmacists (ASHP) - ASHP discussion forum (Sign up for free) recent topics of discussion include: Remdesivir in ESRD and AKI; Vitamin C renal dosing ISMP - COVID-19 Medication Safety Resource Page - link - Medication Safety Officers Society (MSOS) at the ISMP discussion forum (Sign up for free) recent topics of discussion include: Medication/Nutrition support; Independent double check and COVID - Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States? Slides and recording now available. JOURNAL ARTICLES Am J Health-Syst Pharm - Perspectives from the frontline: A pharmacy department’s response to the COVID-19 pandemic – link - Considerations for development of pharmacy support models for COVID-19 alternate care sites - link - Pandemic places pharmacist in unexpected role - link Ann Intensive Care - Ethical dilemmas due to the Covid-19 pandemic - link Ann Intern Med - Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points from the American College of Physicians (Version 1) - link BMJ Nutrition, Prevention & Health - Zinc as nutritional intervention and prevention measure for COVID–19 disease - link Br J Clin Pharmacol - Editorial: A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments - link British Journal of General Practice 2 - Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018 - link Circulation - Systemic Inflammatory Response Syndrome is a Major Contributor to COVID-19-Associated Coagulopathy: Insights from a Prospective Single- Center Cohort Study - link Diabetes & Metabolic Syndrome: Clinical Research & Reviews - Cardiac biomarker-based risk stratification algorithm in patients with severe COVID-19 - link Digest Dis Sci - PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19 - link Eur Heart J Cardiovasc Pharmacother - A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers - link JAMA - Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with COVID-19 Diagnosis and Mortality - link - Editorial: Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19 - link JAMA Otolaryngol Head Neck Surg - Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019 – link J Clin Lab Analysis - Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients - link J Neuroimmune Pharmacol - Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review - link QJM: An International Journal of Medicine - Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab – A Case- Controlled Study - link Lancet - COVID-19: can we learn from encephalitis lethargica? - link Lancet Haematology - Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts - link Med J Aust - Perspective: Can AI help in the fight against COVID-19? - link - Unemployment, suicide, and COVID-19: using the evidence to plan for prevention - link MedRxiv - Preprint (awaiting peer review): Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report - link Nature Medicine - Age-dependent effects in the transmission and control of COVID-19 epidemics - link NEJM Catalyst - Case study: Developing Perioperative Covid-19 Testing Protocols to Restore Surgical Services - link Pharm J - Heparin and zilucoplan added to COVID-19 ACCORD trials platform - link - The importance of good mentoring, during the COVID-19 pandemic and beyond - link 3 REPORTS AND PUBLICATIONS – AUSTRALIA Australian Institute for Health and Welfare (AIHW) - Residential aged care quality indicators - link - Aged Care Data: Commonwealth Home Support Program - link - Aged Care Data: Aboriginal and Torres Strait Islander Australians using aged care - link NSW Health Intranet - Incident Management Policy - link PBS - Seventh Community Pharmacy Agreement (7CPA) - link REPORTS AND PUBLICATIONS – INTERNATIONAL Agency for Healthcare Research and Quality (AHRQ) USA - Characteristics and Costs of Potentially Preventable Inpatient Stays - link - Hospital Burden of Opioid-Related Inpatient Stays - link Canadian Agency for Drugs and Technologies in Health - Pioglitazone for Type 2 Diabetes Mellitus and Pre-Diabetes: A Review of Safety - link - Adalimumab for Adult Patients with Plaque Psoriasis: A Review of Clinical Effectiveness - link electronic Medicines Compendium (eMC) (UK) - New products - Esperoct (turoctocog alfa pegol) for the treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia A - Sarclisa (isatuximab) for treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor Food and Drug Administration (FDA) USA - New Drug approvals -- Crysvita (burosumab-twza) for Rare Disease that Causes Low Phosphate Blood Levels, Bone Softening Medicines and Healthcare products Regulatory Agency (MHRA) - Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy - link - Decision: Atezolizumab in combination with bevacizumab for the treatment of adult patients with unresectable hepatocellular carcinoma who have received no prior systemic therapy - link National Institute for Health and Clinical Excellence (NICE) UK - QS161 Sepsis (updated) - TA633 Ustekinumab for treating moderately to severely active ulcerative colitis - Shared learning database: Prescribing guidelines for patients with a first episode psychosis - link The National Academies Press - Nutrition During Pregnancy and Lactation - link - An Examination of Emerging Bioethical Issues in Biomedical Research - link Specialist Pharmacy Service - Sexual Health Patient Group Direction (PGD) Templates (doxycycline, azithromycin, PrEP) MEDICATION SAFETY CEC Medication Safety Communication: Triamcinolone acetonide injection – link 4 electronic Medicines Compendium (eMC) (UK) - Revised SPCs -- Cablivi (caplacizumab) - dosing for TTP age ≥ 12 years and weighing ≥40 kg same as adults -- Constella (linaclotide) - urticaria added as uncommon adverse reaction -- Multaq (dronedarone) likely to increase the exposure of rivaroxaban (a CYP3A4 and P-gp substrate) and may increase the risk of bleeding -- Onpattro (patisiran) - hypotension and syncope added as potential infusion related reactions -- ViePax (venlafaxine hydrochloride) XL - stress cardiomyopathy added as undesirable effect with unknown frequency Food and Drug Administration (FDA) USA - FDA advises consumers not to use hand sanitizer products manufactured by Eskbiochem - link Health Canada – MedEffect Notice - Summary